Aldeyra Therapeutics, Inc. (ALDX)

NASDAQ: ALDX · Real-Time Price · USD

1.585

+0.065 (4.28%)

At close: Jul 27, 2026, 4:00 PM EDT

1.640

+0.055 (3.47%)

Pre-market: Jul 28, 2026, 7:35 AM EDT

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	65	70.04	54.53	142.82	144.42	229.79
Short-Term Investments	-	-	46.62	-	29.88	-
Cash & Short-Term Investments	65	70.04	101.15	142.82	174.3	229.79
Cash Growth	-27.82%	-30.76%	-29.18%	-18.06%	-24.15%	195.14%
Other Current Assets	1.27	1.74	2.92	4.99	6.72	2.96
Total Current Assets	66.27	71.78	104.07	147.81	181.02	232.75
Net Property, Plant & Equipment	0.21	0.28	0.27	0.52	0.27	0.38
Other Long-Term Assets	-	-	0.27	-	-	-
Total Assets	66.48	72.06	104.61	148.33	181.29	233.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.14	0.16	0.18	1.34	0.13	1.02
Accrued Expenses	2.67	6.12	12.12	5.54	14.07	10.52
Current Portion of Long-Term Debt	15.3	15.25	0.03	15.15	0.91	-
Current Portion of Leases	0.21	0.28	0.27	0.24	0.25	0.23
Unearned Revenue	6	6	6	-	-	-
Total Current Liabilities	24.33	27.81	18.6	22.26	15.36	11.77
Long-Term Debt	-	-	15	-	14.92	15.5
Long-Term Leases	-	-	-	0.27	-	0.13
Other Long-Term Liabilities	-	-	-	6	-	-
Total Long-Term Liabilities	-	-	15	6.27	14.92	15.63
Total Liabilities	24.33	27.81	33.6	28.53	30.28	27.4

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-in Capital	529.51	528.15	521.02	513.99	507.77	500.37
Accumulated Other Comprehensive Income	-	-	0.04	-	-0.1	-
Retained Earnings	-487.41	-483.96	-450.11	-394.26	-356.72	-294.69
Shareholders' Equity	42.16	44.25	71	119.8	151.01	205.74
Total Liabilities & Equity	66.48	72.06	104.61	148.33	181.29	233.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	15.51	15.53	15.3	15.66	16.08	15.86
Net Cash (Debt)	49.49	54.51	85.85	127.17	158.22	213.93
Net Cash Growth	-33.56%	-36.50%	-32.49%	-19.63%	-26.04%	242.12%
Net Cash Per Share	0.82	0.91	1.44	2.16	2.71	3.96
Book Value	42.16	44.25	71	119.8	151.01	205.74
Book Value Per Share	0.70	0.74	1.19	2.03	2.59	3.81
Tangible Book Value	42.16	44.25	71	119.8	151.01	205.74
Tangible Book Value Per Share	0.70	0.74	1.19	2.03	2.59	3.81

SEC Filings: 10-K · 10-Q